| GCAEX | VIVIX | GCAEX / VIVIX | |
| Total Expense Ratio | 1.43 | 0.04 | 3,575% |
| Annual Report Gross Expense Ratio | 1.43 | 0.04 | 3,575% |
| Fund Existence | 22 years | 27 years | - |
| Gain YTD | 0.322 | 9.354 | 3% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 437M | 208B | 0% |
| Annual Yield % from dividends | 19.00 | 2.10 | 905% |
| Returns for 1 year | -2.63 | 5.06 | -52% |
| Returns for 3 years | -10.06 | 30.25 | -33% |
| Returns for 5 years | -8.44 | 62.95 | -13% |
| Returns for 10 years | -56.57 | 123.08 | -46% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AHLT | 24.89 | 0.23 | +0.93% |
| American Beacon AHL Trend ETF | |||
| ARMU | 22.74 | 0.19 | +0.84% |
| T-Rex 2X Long ARM Daily Target ETF | |||
| CGGG | 27.69 | 0.20 | +0.73% |
| Capital Group U.S. Large Growth ETF | |||
| OMFS | 41.55 | N/A | N/A |
| Invesco Russell 2000® Dynamic Mltfct ETF | |||
| BMEZ | 14.63 | N/A | N/A |
| BlackRock Health Sciences Term Trust | |||